Rochester,NY 8/11/2009 11:44:07 PM
Cell Therapeutics, Inc., CTIC - Cell Therapeutics Inc. announced Operating Results its 10-Q
Cell Therapeutics, Inc.
Novel treatments for cancer is developed acquired and commercialized by Cell Therapeutic. Our goal is to build a leading vertically-integrated biopharmaceutical company with a diversified portfolio of oncology drugs and drug candidates.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Sign up for our free alerts newsletter.
The company\'s research and in-licensing activities are concentrated on identifying new less toxic and more effective ways to treat cancer. The company has received fast-track designation from the FDA for this indication and expect to receive priority review which would expedite the FDA\'s review of our application.
StockEinstein.com has a dedicated team uncovering stocks ready to break and run. We apply time tested criteria and when one of these stocks meets or exceeds our benchmarks, our subscribers are immediately notified directly to their in-box.
This is a free service available only to our subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
During 2009 our alerts have resulted in an average price gain of 80%+.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
